ClinicalTrials.Veeva

Menu

Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.

G

Grupo Rehabilitacion en Salud

Status and phase

Completed
Phase 4

Conditions

Musculoskeletal Pain
Myofascial Trigger Point Pain
Myofascial Pain Syndrome
Pain

Treatments

Other: Lidocaine injection + physical therapy
Drug: Lidocaine injection
Other: Physical therapy

Study type

Interventional

Funder types

Other
NETWORK

Identifiers

NCT01250184
GrupoRS0001

Details and patient eligibility

About

Background: Myofascial pain syndrome (MPS) of the shoulder girdle and cervical region is a common musculoskeletal problem that is often chronic or recurrent. It has demonstrated the effectiveness of different treatments such as exercise, injection but not comparing them with each other. The objective of this research was to demonstrate whether lidocaine injection into trigger points combined with a physical therapy program was more effective than each separatetreatment in improving pain, function and quality of life in a group of patients with myofascial pain syndrome (MPS) of the shoulder girdle and cervical region.

Design: Single-blind, randomized, controlled clinical trial with three parallel groups in the departments of physical medicine and rehabilitation of two urban hospitals. There were 127 patients with myofascial pain in the shoulder girdle for more than six weeks in length and pain greater than 40 mm on the visual analog scale (VAS). There were three intervention groups: physical therapy (PT), lidocaine injection (LI), or the combination of both (PT + LI). The primary outcome at one month was the VAS, and the secondary outcomes were measured using the SF36 pain scaleat one and three months.

Keywords: Myofascial pain, trigger points, lidocaine injection, physical therapy.

Full description

We propose a double blind randomized controlled clinical trial, in different health centers in Medellin. The subjects are patients with myofascial trigger points (MTP) in muscles of the shoulder girdle (levator scapulae, trapezius, infraspinatus) diagnosed by neck ans shoulder pain lasting langer than 6 weeks, and that have not received rehabilitation treatment and are not currently taking analgesic medications. We have calculated a sample of 45 patients in each group.

The physical and rehabilitation doctors who evaluated the patients and the nurse who assessed the patients were blinded to treatment allocation. Physicians who performed the MTP injection did not participate in the evaluation of primary and secondary outcomes. Physical therapists who conducted the therapeutic exercise program did not participate in the evaluation of primary and secondary outcomes.

Enrollment

127 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Cervical Pain at least six weeks
  • At least 40 mm in the VAS
  • They cannot been received treatment like physical therapy or analgesics
  • Maximum score of PHQ 16 points

Exclusion criteria

  • Depression
  • Fibromyalgia
  • Cervical Radiculopathy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

127 participants in 3 patient groups

Physical Therapy
Active Comparator group
Description:
Twelve sessions, 3 per week.
Treatment:
Other: Physical therapy
Lidocaine injection
Active Comparator group
Description:
Blocking the myofascial trigger point (MTP) with lidocaine injection, unique dose.
Treatment:
Drug: Lidocaine injection
Lidocaine injection + physical therapy
Experimental group
Description:
Blocking the Myofascial trigger point (MTP) with lidocaine injection plus a standarized therapeutic exercise program, twelve sessions, 3 per week.
Treatment:
Other: Lidocaine injection + physical therapy

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems